MARLENE DEBEL - 24 Feb 2022 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Role
Director
Signature
/s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact
Issuer symbol
RJF
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
25 Feb 2022, 14:08:52 UTC
Previous filing
24 Feb 2022
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RJF Common Stock Options Exercise $0 +1,925 +318% $0.000000 2,530 24 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RJF Restricted Stock Units Award $0 +1,683 +87% $0.000000 3,608 24 Feb 2022 Common Stock 1,683 Direct F1, F2
transaction RJF Restricted Stock Units Options Exercise $0 -1,925 -53% $0.000000 1,683 24 Feb 2022 Common Stock 1,925 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2 The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2023.
F3 The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.
F4 The RSU grant was previously reported as covering 1,283 shares awarded on February 18, 2021, but was adjusted to reflect the 3-for-2 stock split by means of a stock dividend that occurred on September 21, 2021.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of RSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.